Evidence map›Paper›PMID 28130310›Full record

ArticleDiabetes2017

Reestablishment of Glucose Inhibition of Glucagon Secretion in Small Pseudoislets.

Christopher A Reissaus, David W Piston

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 52 citations in OpenAlex.

  1. Role of complexin 2 in the regulation of hormone secretion from the islet of Langerhans.American journal of physiology. Endocrinology and metabolism · 2025
    Article
  2. Review
  3. Paracrine Signaling by Pancreatic Islet Cilia.Current opinion in endocrine and metabolic research · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Christopher A ReissausCell Biology and Physiology, Washington University School of Medicine in St. Louis, St. Louis, MO, and Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN.
David W PistonCell Biology and Physiology, Washington University School of Medicine in St. Louis, St. Louis, MO, and Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN piston@wustl.edu.ORCID 0000-0002-1200-3116
Vanderbilt University · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI AIMEE S JAMES · 2001 to 2026
$128.0M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ALVIN C POWERS · 2012 to 2026
$29.3M
WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Clay F. Semenkovich · 2013 to 2026
$27.1M
TRANSGENICS COREP60DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI SCHAFFER, JEAN E. · 1986 to 2012
$25.2M
MULTIDISCIPLINARY TRAINING IN MOLECULAR ENDOCRINOLOGYT32DK007563 · NIDDK · VANDERBILT UNIVERSITY · PI Richard M O'Brien · 1988 to 2026
$15.9M
Dopamine Action in Pancreatic Islet FunctionR01DK085064 · NIDDK · WASHINGTON UNIVERSITY · PI PISTON, DAVID W · 2010 to 2014
$1.7M
Pancreatic Islets Dynamics Regulating Glucagon SecretionR01DK098659 · NIDDK · WASHINGTON UNIVERSITY · PI PISTON, DAVID W · 2013 to 2016
$1.3M
Multi-Function Laser Scanning MicroscopeS10RR025649 · NCRR · VANDERBILT UNIVERSITY · PI PISTON, DAVID W · 2009 to 2009
$499k
Multiphoton microscope upgradeS10OD010681 · OD · VANDERBILT UNIVERSITY · PI PISTON, DAVID W · 2012 to 2012
$436k
NCI NIH HHS P30 CA091842NCRR NIH HHS S10 RR025649NIDDK NIH HHS P30 DK020579NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P60 DK020579NIDDK NIH HHS R01 DK085064NIDDK NIH HHS R01 DK098659NIDDK NIH HHS T32 DK007563NIH HHS S10 OD010681
6 · The paper itself

Abstract

Misregulated hormone secretion from the islet of Langerhans is central to the pathophysiology of diabetes. Although insulin plays a key role in glucose regulation, the importance of glucagon is increasingly acknowledged. However, the mechanisms that regulate glucagon secretion from α-cells are still unclear. We used pseudoislets reconstituted from dispersed islet cells to study α-cells with and without various indirect effects from other islet cells. Dispersed islet cells secrete aberrant levels of glucagon and insulin at basal and elevated glucose levels. When cultured, murine islet cells reassociate to form pseudoislets, which recover normal glucose-regulated hormone secretion, and human islet cells follow a similar pattern. We created small (∼40-µm) pseudoislets using all of the islet cells or only some of the cell types, which allowed us to characterize novel aspects of regulated hormone secretion. The recovery of regulated glucagon secretion from α-cells in small pseudoislets depends upon the combined action of paracrine factors, such as insulin and somatostatin, and juxtacrine signals between EphA4/7 on α-cells and ephrins on β-cells. Although these signals modulate different pathways, both appear to be required for proper inhibition of glucagon secretion in response to glucose. This improved understanding of the modulation of glucagon secretion can provide novel therapeutic routes for the treatment of some individuals with diabetes.

Indexed as

ActinsAnimalsCell CommunicationCells, CulturedCyclic AMPEphrinsFlow CytometryGlucagonGlucagon-Secreting CellsGlucoseInsulinInsulin-Secreting CellsInsulin SecretionIslets of LangerhansMiceMice, TransgenicActinsCyclic AMPEphrinsGlucagonGlucoseInsulinReceptor, EphA4Receptor, EphA7Somatostatin

Identifiers

PMID28130310
PMCPMC5360306
OpenAlexW2580251625

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.